DealsApr 28, 2026, 07:47 AM
AIDX Warrants Exercise Price Reduced to $2.25 per Share
AI Summary
20/20 Biolabs, Inc. (AIDX) announced a global amendment with Streeterville Capital, LLC, on April 23, 2026, significantly reducing the exercise price of its outstanding warrants. The exercise price for Warrants 1, 2, and 3 was lowered to $2.25 per share from their original prices of $8.00 and $11.42. The company maintains a 90-day termination right for the amendment.
Key Highlights
- On April 23, 2026, 20/20 Biolabs (AIDX) entered a global amendment with Streeterville Capital, LLC.
- The exercise price of Warrants 1, 2, and 3 was reduced to $2.25 per share.
- The company retains a 90-day right to terminate the amendment with two trading days' notice.
- Warrant 1 (62,500 shares) was originally issued on Nov 17, 2025, with an $8.00 exercise price.
- Warrant 2 (62,500 shares) was originally issued on Feb 9, 2026, with an $8.00 exercise price.
- Warrant 3 (3,502,627 shares) was originally issued on Feb 19, 2026, with an $11.42 exercise price.
Price Impact
More from AIDX